Rare / orphan disease drugs

Discover the landscape of Rare / orphan disease drugs in China’s pharmaceutical industry. Fineline Info & Tech provides reliable data, news, and intelligence on Rare / orphan disease drugs, helping you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Lifetech's ICS Elpis Bioresorbable Peripheral Stent Enters NMPA Green Channel – World's First Fully Bioresorbable Covered Stent System for Iliac Artery Disease
CompanyMedical Device

Lifetech’s ICS Elpis Bioresorbable Peripheral Stent Enters NMPA Green Channel – World’s First Fully Bioresorbable Covered Stent System for Iliac Artery Disease

Lifetech Scientific Corporation (HKG: 1302) announced that the ICS Elpis Bioresorbable Peripheral Balloon‑Expandable Covered Stent System, independently developed by its subsidiary Yuanxin Technology (Shenzhen) Co., Ltd., was approved for entry…

GE HealthCare Launches Global Clinical Evaluation of StarGuide GXi – Next‑Generation Digital 4D SPECT/CT Spans Three Continents and Five Elite Institutions

GE HealthCare Launches Global Clinical Evaluation of StarGuide GXi – Next‑Generation Digital 4D SPECT/CT Spans Three Continents and Five Elite Institutions

Sisram Medical's Profhilo Facial Registration Accepted by NMPA – BDDE‑Free Hyaluronic Acid Biostimulator Poised for China's Aesthetics Market

Sisram Medical’s Profhilo Facial Registration Accepted by NMPA – BDDE‑Free Hyaluronic Acid Biostimulator Poised for China’s Aesthetics Market

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

BDgene Advances CRISPR-Based BD111 for Herpes Keratitis with IND Filing

CompanyR&D

Lundbeck Initiates TALISMAN Study on Multiple System Atrophy in China and EU

CompanyDrug

Lee’s Pharmaceutical Wins NMPA Approval for ALS Drug Teglutik

CompanyDrug

Takeda’s Obizur Accepted by China’s NMPA for Acquired Hemophilia A Treatment

CompanyDeals

Quoin Pharmaceuticals Partners with WinHealth for Rare Disease Treatments in Greater China

CompanyDrug

Jiangsu Hengrui Medicine’s Hetrombopag Olamine Receives FDA Orphan Drug Designation for ITP

CompanyDrug

Zai Lab Ltd Makes FcRn Antagonist Efgartigimod Available for Myasthenia Gravis Treatment

Policy / Regulatory

NHSA Releases Draft Proposals for NRDL Annual Renewal Process

Show More